Published December 23, 2013
| Supplemental Material + Accepted Version
Journal Article
Open
A Chemical Epitope-Targeting Strategy for Protein Capture Agents: The Serine 474 Epitope of the Kinase Akt2
Abstract
Target and click: Peptide ligands targeted to the C-terminal motif of the kinase Akt2 were obtained by combining phosphate recognition of a dinuclear zinc(II) complex with in situ click chemistry to target this epitope. The peptide ligands (shown as XXXXX) selectively bind the C-terminal polypeptide of Akt2, and are selective for Akt2 relative to the Akt1 and Akt3 isoforms. The ligands differentially modulate Akt2 activity.
Additional Information
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Received: July 7, 2013; Revised: September 23, 2013. Article first published online: 19 Nov. 2013. This work was supported by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. Additional personnel or facilities support from the National Cancer Institute (5U54 CA119347: J.R.H. PI), the Grand Duchy of Luxembourg, and the Bill and Melinda Gates Foundation is acknowledged.Attached Files
Accepted Version - nihms589080.pdf
Supplemental Material - anie_201305882_sm_miscellaneous_information.pdf
Files
anie_201305882_sm_miscellaneous_information.pdf
Files
(21.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:585779eb818c5d5bd750c77f8616985f
|
19.9 MB | Preview Download |
|
md5:bfc5a9b437d6416605e0e98d10bea05e
|
1.5 MB | Preview Download |
Additional details
- PMCID
- PMC4059071
- Eprint ID
- 42839
- Resolver ID
- CaltechAUTHORS:20131204-154453202
- W911NF-09-0001
- Army Research Office (ARO)
- 5U54 CA119347
- NIH
- Grand Duchy of Luxembourg
- Bill and Melinda Gates Foundation
- National Cancer Institute
- Created
-
2013-12-05Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field